Login
Evidence Feed
About
Diagnostics
New
Top genes
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
CANCER:
Pancreatic Adenocarcinoma
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Related cancers:
‹
Pancreatic Cancer (499
)
Pancreatic Ductal Adenocarcinoma (133
)
Pancreatic Cancer (499
)
Pancreatic Ductal Adenocarcinoma (133
)
›
Associations
(81)
News
Trials
VERI cancer hierarchy
Reset Filters
No biomarker
Pancreatic Adenocarcinoma
No biomarker
Pancreatic Adenocarcinoma
gemcitabine + albumin-bound paclitaxel
Sensitive: A1 - Approval
gemcitabine + albumin-bound paclitaxel
Sensitive
:
A1
gemcitabine + albumin-bound paclitaxel
Sensitive: A1 - Approval
gemcitabine + albumin-bound paclitaxel
Sensitive
:
A1
No biomarker
Pancreatic Adenocarcinoma
No biomarker
Pancreatic Adenocarcinoma
5-fluorouracil + leucovorin calcium + nanoliposomal irinotecan
Sensitive: A1 - Approval
5-fluorouracil + leucovorin calcium + nanoliposomal irinotecan
Sensitive
:
A1
5-fluorouracil + leucovorin calcium + nanoliposomal irinotecan
Sensitive: A1 - Approval
5-fluorouracil + leucovorin calcium + nanoliposomal irinotecan
Sensitive
:
A1
No biomarker
Pancreatic Adenocarcinoma
No biomarker
Pancreatic Adenocarcinoma
LV5FU2
Sensitive: A2 - Guideline
LV5FU2
Sensitive
:
A2
LV5FU2
Sensitive: A2 - Guideline
LV5FU2
Sensitive
:
A2
No biomarker
Pancreatic Adenocarcinoma
No biomarker
Pancreatic Adenocarcinoma
CAPOX
Sensitive: A2 - Guideline
CAPOX
Sensitive
:
A2
CAPOX
Sensitive: A2 - Guideline
CAPOX
Sensitive
:
A2
NTRK3 fusion
Pancreatic Adenocarcinoma
NTRK3 fusion
Pancreatic Adenocarcinoma
larotrectinib
Sensitive: A2 - Guideline
larotrectinib
Sensitive
:
A2
larotrectinib
Sensitive: A2 - Guideline
larotrectinib
Sensitive
:
A2
NTRK2 fusion
Pancreatic Adenocarcinoma
NTRK2 fusion
Pancreatic Adenocarcinoma
larotrectinib
Sensitive: A2 - Guideline
larotrectinib
Sensitive
:
A2
larotrectinib
Sensitive: A2 - Guideline
larotrectinib
Sensitive
:
A2
NTRK1 fusion
Pancreatic Adenocarcinoma
NTRK1 fusion
Pancreatic Adenocarcinoma
larotrectinib
Sensitive: A2 - Guideline
larotrectinib
Sensitive
:
A2
larotrectinib
Sensitive: A2 - Guideline
larotrectinib
Sensitive
:
A2
NTRK3 fusion
Pancreatic Adenocarcinoma
NTRK3 fusion
Pancreatic Adenocarcinoma
entrectinib
Sensitive: A2 - Guideline
entrectinib
Sensitive
:
A2
entrectinib
Sensitive: A2 - Guideline
entrectinib
Sensitive
:
A2
No biomarker
Pancreatic Adenocarcinoma
No biomarker
Pancreatic Adenocarcinoma
erlotinib
Sensitive: A2 - Guideline
erlotinib
Sensitive
:
A2
erlotinib
Sensitive: A2 - Guideline
erlotinib
Sensitive
:
A2
No biomarker
Pancreatic Adenocarcinoma
No biomarker
Pancreatic Adenocarcinoma
capecitabine
Sensitive: A2 - Guideline
capecitabine
Sensitive
:
A2
capecitabine
Sensitive: A2 - Guideline
capecitabine
Sensitive
:
A2
No biomarker
Pancreatic Adenocarcinoma
No biomarker
Pancreatic Adenocarcinoma
5-fluorouracil + capecitabine
Sensitive: A2 - Guideline
5-fluorouracil + capecitabine
Sensitive
:
A2
5-fluorouracil + capecitabine
Sensitive: A2 - Guideline
5-fluorouracil + capecitabine
Sensitive
:
A2
No biomarker
Pancreatic Adenocarcinoma
No biomarker
Pancreatic Adenocarcinoma
5-fluorouracil
Sensitive: A2 - Guideline
5-fluorouracil
Sensitive
:
A2
5-fluorouracil
Sensitive: A2 - Guideline
5-fluorouracil
Sensitive
:
A2
No biomarker
Pancreatic Adenocarcinoma
No biomarker
Pancreatic Adenocarcinoma
gemcitabine
Sensitive: A2 - Guideline
gemcitabine
Sensitive
:
A2
gemcitabine
Sensitive: A2 - Guideline
gemcitabine
Sensitive
:
A2
No biomarker
Pancreatic Adenocarcinoma
No biomarker
Pancreatic Adenocarcinoma
gemcitabine + capecitabine
Sensitive: A2 - Guideline
gemcitabine + capecitabine
Sensitive
:
A2
gemcitabine + capecitabine
Sensitive: A2 - Guideline
gemcitabine + capecitabine
Sensitive
:
A2
BRCA1 mutation
Pancreatic Adenocarcinoma
BRCA1 mutation
Pancreatic Adenocarcinoma
cisplatin + gemcitabine
Sensitive: A2 - Guideline
cisplatin + gemcitabine
Sensitive
:
A2
cisplatin + gemcitabine
Sensitive: A2 - Guideline
cisplatin + gemcitabine
Sensitive
:
A2
BRCA2 mutation
Pancreatic Adenocarcinoma
BRCA2 mutation
Pancreatic Adenocarcinoma
cisplatin + gemcitabine
Sensitive: A2 - Guideline
cisplatin + gemcitabine
Sensitive
:
A2
cisplatin + gemcitabine
Sensitive: A2 - Guideline
cisplatin + gemcitabine
Sensitive
:
A2
PALB2 mutation
Pancreatic Adenocarcinoma
PALB2 mutation
Pancreatic Adenocarcinoma
cisplatin + gemcitabine
Sensitive: A2 - Guideline
cisplatin + gemcitabine
Sensitive
:
A2
cisplatin + gemcitabine
Sensitive: A2 - Guideline
cisplatin + gemcitabine
Sensitive
:
A2
No biomarker
Pancreatic Adenocarcinoma
No biomarker
Pancreatic Adenocarcinoma
5-fluorouracil + irinotecan
Sensitive: A2 - Guideline
5-fluorouracil + irinotecan
Sensitive
:
A2
5-fluorouracil + irinotecan
Sensitive: A2 - Guideline
5-fluorouracil + irinotecan
Sensitive
:
A2
NTRK1 fusion
Pancreatic Adenocarcinoma
NTRK1 fusion
Pancreatic Adenocarcinoma
entrectinib
Sensitive: A2 - Guideline
entrectinib
Sensitive
:
A2
entrectinib
Sensitive: A2 - Guideline
entrectinib
Sensitive
:
A2
MSI-H/dMMR
Pancreatic Adenocarcinoma
MSI-H/dMMR
Pancreatic Adenocarcinoma
pembrolizumab
Sensitive: A2 - Guideline
pembrolizumab
Sensitive
:
A2
pembrolizumab
Sensitive: A2 - Guideline
pembrolizumab
Sensitive
:
A2
TMB-H
Pancreatic Adenocarcinoma
TMB-H
Pancreatic Adenocarcinoma
pembrolizumab
Sensitive: A2 - Guideline
pembrolizumab
Sensitive
:
A2
pembrolizumab
Sensitive: A2 - Guideline
pembrolizumab
Sensitive
:
A2
NTRK2 fusion
Pancreatic Adenocarcinoma
NTRK2 fusion
Pancreatic Adenocarcinoma
entrectinib
Sensitive: A2 - Guideline
entrectinib
Sensitive
:
A2
entrectinib
Sensitive: A2 - Guideline
entrectinib
Sensitive
:
A2
BRCA2 mutation
Pancreatic Adenocarcinoma
BRCA2 mutation
Pancreatic Adenocarcinoma
FOLFIRINOX
Sensitive: A2 - Guideline
FOLFIRINOX
Sensitive
:
A2
FOLFIRINOX
Sensitive: A2 - Guideline
FOLFIRINOX
Sensitive
:
A2
PALB2 mutation
Pancreatic Adenocarcinoma
PALB2 mutation
Pancreatic Adenocarcinoma
rucaparib
Sensitive: A2 - Guideline
rucaparib
Sensitive
:
A2
rucaparib
Sensitive: A2 - Guideline
rucaparib
Sensitive
:
A2
BRCA2 mutation
Pancreatic Adenocarcinoma
BRCA2 mutation
Pancreatic Adenocarcinoma
rucaparib
Sensitive: A2 - Guideline
rucaparib
Sensitive
:
A2
rucaparib
Sensitive: A2 - Guideline
rucaparib
Sensitive
:
A2
BRCA1 mutation
Pancreatic Adenocarcinoma
BRCA1 mutation
Pancreatic Adenocarcinoma
rucaparib
Sensitive: A2 - Guideline
rucaparib
Sensitive
:
A2
rucaparib
Sensitive: A2 - Guideline
rucaparib
Sensitive
:
A2
BRCA1 mutation
Pancreatic Adenocarcinoma
BRCA1 mutation
Pancreatic Adenocarcinoma
FOLFIRINOX
Sensitive: A2 - Guideline
FOLFIRINOX
Sensitive
:
A2
FOLFIRINOX
Sensitive: A2 - Guideline
FOLFIRINOX
Sensitive
:
A2
No biomarker
Pancreatic Adenocarcinoma
No biomarker
Pancreatic Adenocarcinoma
GTX
Sensitive: A2 - Guideline
GTX
Sensitive
:
A2
GTX
Sensitive: A2 - Guideline
GTX
Sensitive
:
A2
PALB2 mutation
Pancreatic Adenocarcinoma
PALB2 mutation
Pancreatic Adenocarcinoma
FOLFIRINOX
Sensitive: A2 - Guideline
FOLFIRINOX
Sensitive
:
A2
FOLFIRINOX
Sensitive: A2 - Guideline
FOLFIRINOX
Sensitive
:
A2
No biomarker
Pancreatic Adenocarcinoma
No biomarker
Pancreatic Adenocarcinoma
FOLFOX
Sensitive: A2 - Guideline
FOLFOX
Sensitive
:
A2
FOLFOX
Sensitive: A2 - Guideline
FOLFOX
Sensitive
:
A2
BRCA2 mutation
Pancreatic Adenocarcinoma
BRCA2 mutation
Pancreatic Adenocarcinoma
olaparib
Sensitive: A2 - Guideline
olaparib
Sensitive
:
A2
olaparib
Sensitive: A2 - Guideline
olaparib
Sensitive
:
A2
BRCA1 mutation
Pancreatic Adenocarcinoma
BRCA1 mutation
Pancreatic Adenocarcinoma
olaparib
Sensitive: A2 - Guideline
olaparib
Sensitive
:
A2
olaparib
Sensitive: A2 - Guideline
olaparib
Sensitive
:
A2
^
^
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login